Security key
G0360L134
Altamira Therapeutics Ltd. - Class A Common Stock, par value $0.0001 per share (CYTOF)
CUSIP: G0360L134
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Class A Common Stock, par value $0.0001 per share
- Total 13F shares
- 7,680
- Total 13F value
- $26,726
- Share change
- +7,680
- SEC-reported price per share
- $3.48
- Number of holders
- 4
- Value change
- +$26,726
- Number of buys
- 4
- Shares outstanding
- 3,798,838
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
4
Top holders
4
CYTOF full security history
Ownership snapshot
Full 13F holder table
Altamira Therapeutics Ltd. SEC filings
Altamira Therapeutics Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of CYTOF - Altamira Therapeutics Ltd. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/8
Latest evidence
30 Sep 2023
13F
Highest disclosed value: $202,691
8 rows are not safely comparable across share classes.
Showing 1-6 of 8 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $202.7K.
0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$202.7K
CITADEL ADVISORS LLC
$9.4K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$2.5K
XTX Topco Ltd
$2.4K
MORGAN STANLEY
$122
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$202,691
829,000 shares
|
— | 30 Sep 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$9,447
39,165 shares
|
— | 30 Sep 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
denominator unverified
|
$2,457
10,185 shares
|
— | 30 Sep 2023 |
| XTX Topco Ltd |
13F
Company
|
—
denominator unverified
|
$2,444
10,131 shares
|
— | 30 Sep 2023 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$122
500 shares
|
— | 30 Sep 2023 |
| GROUP ONE TRADING LLC |
13F
Company
|
—
denominator unverified
|
$72
298 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
7,680
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
0
Q4 2023 holders
4
Holder diff
4
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|